Literature DB >> 11170865

Targeting tumor vasculature with homing peptides from phage display.

E Ruoslahti1.   

Abstract

Tumor vasculature expresses a number of molecular markers at much lower levels than those seen in the blood vessels of normal tissues, and in some cases, such markers are undetectable. The presence of these markers relates to angiogenesis; the same markers are shared by all blood vessels undergoing angiogenesis. The endothelial cells, pericytes and smooth muscle cells, and the vascular extracellular matrix in angiogenic vessels can each express such markers. Molecularly, they represent vascular growth factor receptors, cell adhesion proteins and their receptors. Screening of phage display libraries for peptides that home to tumor vasculature when injected into mice has recently provided a new tool for analyzing the distinguishing features of tumor vasculature. Tumor-homing peptides isolated in this manner, as well as an antibody against a form of fibronectin expressed in tumor blood vessels, have been found to serve as targeting devices to concentrate drugs and other therapeutic materials to tumors in in vivo models. Such a targeting strategy can therefore potentially improve the efficacy of drugs and reduce their side effects. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11170865     DOI: 10.1006/scbi.2000.0334

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  37 in total

1.  Tumor-targeted delivery of liposome-encapsulated doxorubicin by use of a peptide that selectively binds to irradiated tumors.

Authors:  Amanda Lowery; Halina Onishko; Dennis E Hallahan; Zhaozhong Han
Journal:  J Control Release       Date:  2010-11-12       Impact factor: 9.776

2.  Facile synthesis of biocompatible gold nanoparticles from Vites vinefera and its cellular internalization against HBL-100 cells.

Authors:  Kanchana Amarnath; Nina Liza Mathew; Jayshree Nellore; Chagam Reddy Venkat Siddarth; Jayanthi Kumar
Journal:  Cancer Nanotechnol       Date:  2011-09-15

3.  Gene expression signatures of site-specificity in cancer metastases.

Authors:  Franz Hartung; Aditya Patil; Rohan J Meshram; Georg F Weber
Journal:  Clin Exp Metastasis       Date:  2019-09-25       Impact factor: 5.150

Review 4.  Peptide-displaying phage technology in glycobiology.

Authors:  Michiko N Fukuda
Journal:  Glycobiology       Date:  2011-09-19       Impact factor: 4.313

5.  Nanocrystal targeting in vivo.

Authors:  Maria E Akerman; Warren C W Chan; Pirjo Laakkonen; Sangeeta N Bhatia; Erkki Ruoslahti
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-16       Impact factor: 11.205

6.  Glycosylation might provide endothelial zip codes for organ-specific leukocyte traffic into inflammatory sites.

Authors:  Jutta Renkonen; Olli Tynninen; Pekka Häyry; Timo Paavonen; Risto Renkonen
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

7.  Affinity maturation of an ERBB2-targeted SPECT imaging peptide by in vivo phage display.

Authors:  Benjamin M Larimer; William D Thomas; George P Smith; Susan L Deutscher
Journal:  Mol Imaging Biol       Date:  2014-08       Impact factor: 3.488

8.  Identification of chondrocyte-binding peptides by phage display.

Authors:  Crystal S F Cheung; Julian C Lui; Jeffrey Baron
Journal:  J Orthop Res       Date:  2013-02-25       Impact factor: 3.494

Review 9.  Paradigm shift in bacteriophage-mediated delivery of anticancer drugs: from targeted 'magic bullets' to self-navigated 'magic missiles'.

Authors:  Valery A Petrenko; James W Gillespie
Journal:  Expert Opin Drug Deliv       Date:  2016-08-05       Impact factor: 6.648

10.  Treatment of peritoneal carcinomatosis by targeted delivery of the radio-labeled tumor homing peptide bi-DTPA-[F3]2 into the nucleus of tumor cells.

Authors:  Enken Drecoll; Florian C Gaertner; Matthias Miederer; Birgit Blechert; Mario Vallon; Jan M Müller; Andrea Alke; Christof Seidl; Frank Bruchertseifer; Alfred Morgenstern; Reingard Senekowitsch-Schmidtke; Markus Essler
Journal:  PLoS One       Date:  2009-05-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.